OCR Text |
Show NEURO-OPHTHALMOLOGY AT LARGE 17th International Neuro-Ophthalmology Society (INOS) Meeting, Napa, California, June 7-12, 2008 The 17th biennial meeting of the International Neuro- Ophthalmology Society (INOS) was held at the Silverado Resort in Napa, California, June 7-12, 2008. Hosted by Anthony Arnold, MD (Los Angeles, CA), John Keltner, MD (Davis, CA), and Neil Miller, MD (Baltimore, MD), the program consisted of 10 sessions FIG. 1. INOS 2008 co-presidents Anthony Arnold, MD (Los Angeles, CA), Neil Miller, MD (Baltimore, MD), and John Keltner, MD (Davis, CA) enjoy a relaxing moment at the meeting. that covered virtually every topic in neuro-ophthalmol-ogy and featured lectures from 28 invited guests as well as free paper presentations. Two poster sessions consist-ing of 90 submissions were also part of the program. The meeting was attended by 250 physicians from 18 countries. The first session concerned disorders of the optic nerve and featured lectures by Solon Thanos (Mu¨nster, Germany) discussing new concepts in optic nerve regen-eration and repair, John Guy, MD (Miami, FL) discussing his groundbreaking earlier and current work on gene therapy for Leber hereditary optic neuropathy, and Paul Hoffman, MD, PhD (Baltimore, MD) describing the actual and potential effects of electrical stimulation of the optic nerve. The second session concerned the ocular motor system, beginning with a comprehensive review of the effects of tenotomy on congenital and acquired nystag-mus by Lance Optican, PhD (Bethesda, MD), of the National Eye Institute. It was followed by reviews by Christopher Kennard (London, England) of supranuclear disorders of eye movement and by Agnes Wong, MD, PhD (Toronto, ON) of skew deviation and its differentiation from fourth nerve palsy. The third session dealt with the pupil, including a review of the afferent pupillary pathways by Helmut Wilhelm (Tu¨bingen, Germany), lectures by Randy Kardon, MD, PhD (Iowa City, IA) and Aki Kawasaki, MD (Lausanne, Switzerland) on the nature and significance of melanopsin-containing retinal ganglion cells, and a presentation on the cor-relation of the state of alertness and the reactivity of the pupil by Barbara Wilhelm (Tu¨bingen, Germany). The fourth session consisted of several free papers covering a number of areas of neuro-ophthalmology, and the fifth session was devoted to an in-depth discussion of idiopathic intracranial hypertension (IIH), including pre-sentations by Miles Johnston, PhD (Toronto, ON), on the pathways for egress of cerebrospinal fluid, John Pickard (Cambridge, England) on dural venous sinus stenting in patients with IIH, Deborah Friedman, MD (Rochester, NY), on medical therapy for IIH, and Neil Miller, MD, on surgical treatment of IIH. Michael Wall, MD (Iowa City, IA), summed up the information and led a spirited panel discussion. J Neuro-Ophthalmol, Vol. 29, No. 1, 2009 85 J Neuro-Ophthalmol, Vol. 29, No. 1, 2009 FIG. 2. Richard Sogg, MD (Palo Alto, CA), Dahlia Berman- Jensen, MD (Denmark), and William Hoyt, MD (San Francisco, CA), during a break. The sixth session dealt with ocular imaging. John Werner, PhD (Davis, CA), provided an overview of current techniques for imaging of the retina and a glimpse into the not-too-distant future for this field. Helen Danesh-Meyer (Auckland, New Zealand) discussed the use of Heidelberg retinal tomography in neuro-ophthalmology, and Eric Eggenberger, DO (East Lansing, MI) reviewed the optical coherence tomography (OCT) findings in patients enrolled in the Optic Neuritis Treatment Trial. The seventh session covered eye movements and began with a review by Terry Smith, MD (Los Angeles, CA) on current concepts in the immunology of Graves ophthalmopathy. Mark Kupersmith (New York, NY) dis-cussed medical therapies for ocular myasthenia gravis and FIG. 3. Anthony Arnold and his wife, Laura, about to take off for a hot-air balloon adventure. Miller FIG. 4. Jonathan Horton, MD, PhD (San Francisco, CA), and John Guy, MD (Miami, FL) are interrupted during a discussion of their research activities. their significance for conversion to generalized myasthenia, and Irene Gottlob (Leicester, England) described her breakthrough work on medical therapy for congenital and acquired nystagmus. The eighth session consisted of a second series of free paper presentations and was followed by a special lecture given by Esriel Killer (Basel, Switzerland) that explored new concepts in the pathogenesis of IIH. The ninth session was devoted to neuroimaging and featured Philippe Gailloud, MD (Baltimore, MD) discus-sing the current status of interventional neuroradiology for the treatment of disorders of neuro-ophthalmic significance and Pablo Villablanca, MD (Los Angeles, CA) comparing the strengths and weaknesses of MRA versus CT angiography for the diagnosis of various cerebrovascular diseases, including acute third cranial nerve palsy. The tenth and final session was a symposium on multiple sclerosis (MS) and other demyelinating disor-ders. The speakers for this session included Jeffery Cohen, MD (Cleveland, OH), who discussed the current and future treatments of MS, Shelley Cross, MD (Rochester, MN) and Jun-ichi Kira (Fukuoka, Japan), who compared MS and neuromyelitis optica and emphasized the clinical findings and the role of the aquaporin-4 antibody in distinguishing between these disorders. The session concluded with a lecture by Laura Balcer, MD (Phila-delphia, PA) on the usefulness of low-contrast Sloan letters as well as OCT for outcome assessment in MS clinical trials. In addition to the scientific program, social activities included a welcome reception, a hotly contested golf 86 q 2009 Lippincott Williams & Wilkins Neuro-Ophthalmology At Large J Neuro-Ophthalmol, Vol. 29, No. 1, 2009 FIG. 5. Michael Lee, MD (Minneapolis, MN), Prem Subramanian, MD, PhD (Baltimore, MD), Eric Eggenberger, DO (East Lansing, MI), Swaraj Bose, MD (Irvine, CA), and Vivian Rismondo-Stankovich, MD (Baltimore, MD) share a table at the closing banquet. tournament, hot air ballooning, and, of course, extensive wine tasting. Laura Bohannon and her colleagues from Bohannon and Co. were the conference organizers and did a phenomenal job. The next INOS meeting will be held in 2010 in Lyon, France. It will be hosted by Alain Vighetto (Lyon, France) and Catherine Tilikete (Lyon, France) with the assistance of Va l e´rie Biousse, MD (Atlanta, GA). Neil R. Miller, MD Baltimore, Maryland 87 |